---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-073894"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:58:01.373205+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Robin L. Smith resigns from Celularity board effective Dec. 24, 2023

## Summary
- Robin L. Smith, MD, a Class II director, resigned from the board on December 24, 2023.
- Resignation was not due to any disagreement with Celularity on operations, policies, or practices.
- No replacement director has been announced as of the filing date.

## SEC filing metadata
- accession: 0000950170-23-073894
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000095017023073894/0000950170-23-073894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000095017023073894/celu-20231224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-073894
- JSON: https://secwatch.observer/filing/0000950170-23-073894.json
- Plain text: https://secwatch.observer/filing/0000950170-23-073894.txt

## Key facts
- Executive change
  Robin L. Smith, MD resigned as Class II member of the board of directors at Celularity Inc.
  - Action: resigned
  - Role: Class II member of the board of directors
  source text: On December 24, 2023, Robin L. Smith, MD, a Class II member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of her intention to resign as a member of the board effective December 24, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000095017023073894/0000950170-23-073894-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.